Sponsored by: Innerspace, Solo Containment and STERIS Co-Chairs: Richard Denk, Senior Consultant Aseptic Processing and Containment, SKAN AG James Drinkwater, Head of Aseptic Processing and Containment Special Interest Group, PHSS and Head of GMP Compliance, F Ziel GmbH Exploring Effective Strategies and New Regulations for Compliant Pharmaceutical Manufacturing The aseptic processing industry has seen many changes […]

As 2021 marks a major milestone for RAS therapeutics, with the first ever KRAS targeted therapy receiving FDA approval, the once undruggable RAS family of proteins is no longer impossible to crack. With this significant industry shift, this community will no doubt continue going from strength to strength and the future looks bright for future […]

The Cannabinoid Derived Pharmaceuticals Summit is the world’s largest conference devoted exclusively to the production of CDPs for medical conditions using FDA/EMA approval pathways. The 2021 agenda will focus on clinical trial design and commercialization, target biology and pharmacology, GMP-compliant product formulation, drug delivery, and managing the changing regulatory environment (particularly in light of new […]

Returning in September as a digital event, the 2nd Gene Therapy for Ophthalmic Disorders meeting will target the industry’s translational challenges in targeting both rare and common ophthalmic disorders including wet AMD, dry AMD, DME, IRDs and more. Discover novel vectors and administration routes for optimal retinal delivery with 30+ world class speakers from the likes of GenSight Biologics, […]

The 6th PREDiCT: 3D Tissue Models Summit is the only industry-led summit focusing on real-world application of 3D models in drug discovery and development. With 25+ experts sharing fresh case studies on 3D Tissue Models data, how to foster technology maturation, and lower costs to drive industrial adoption, this is a conversation not to miss. Returning as an […]

On the way to maximising the potential of oligo-based medicine Oligonucleotide therapeutics - the emerging medicine class - are harnessing the therapeutic benefit of targeting genetic material via antisense, mRNA, RNAi, saRNA and siRNA. Their market growth: CAGR of 13.7% projected to reach USD 8.2 billion by 2024 is driven by their potential to provide […]

SMi’s Aseptic Processing Conference Exploring aseptic facility design and operation to implement agile contamination control strategies Conference: 22 – 23 September 2021 Location: Copthorne Tara Hotel, London, UK Website: http://www.asepticprocessing.co.uk/PJWL SPONSORED BY: Innerspace & Steris  CHAIRED BY: James Drinkwater, Head of Aseptic Processing & Containment Special Interest Group, PHSS and Richard Denk, DACH Affiliate, ISPE  The aseptic processing industry has seen many […]

This last year has been a brutal reminder as to how crucial it is that we tackle the impending global mental health crisis and find a path towards successful neuropsychiatric drug development. We are proud to be the industry’s definitive and unrivalled forum focused on encapsulating the recent clinical advances across this extremely arduous field. […]

The 12th Annual World Bispecific Summit will deliver a greater scope and penetration of innovative technical content than any other meeting. This year’s re-imagined agenda will cover unique discovery, translational, and manufacturing challenges faced in the bispecific field. Whatever your role and interest, you will leave the meeting with concrete methods to employ into your strategy and pipeline to convert […]

Accelerating R&D to Commercialization by Leveraging Predictive Biomarkers & Clinical Diagnostics Evidence for Best Patient Outcomes in Target Populations The 11th World Clinical Biomarkers & CDx Summit returns in 2021 as the only end-to-end industry-led meeting diving deep into the science of transitioning biomarkers to the clinic, their clinical validation and later commercialization with a […]

Leveraging next gen technologies beyond conventional biomarker drug discovery The emergence of the need for safety and efficacy of a drug subjected to individual patients has made companion diagnostics one of the most sought after topics in the field of In-Vitro Diagnostics. The surge of investment in companion diagnostics has brought forward issues regarding regulations […]

The 2nd Annual B&T Cell-Mediated Autoimmune Disease Drug Development Summit is the only event uniting key B&T cell decision-makers to advance the therapeutic future of autoimmune diseases. Join this community of 60+ pioneers to aid discovery, development, optimization and strategy for a new generation of treatment within this area of vastly unmet clinical need. This […]

SPONSORED BY: Elis Cleanroom and Innerspace CHAIRED BY: Matts Ramstorp, CEO & Founder, BioTekPro Addressing the Microbiological Aspects in Cleanroom Design & Engineering SMi Group are pleased to announce the 2nd Annual Next Generation Pharmaceutical Cleanroom Europe Conference. An event that focuses on cleanroom technology in the pharmaceutical industry, the conference will serve to bridge that gap between the two […]

The latest innovations in digital health and on-body drug delivery for the pharmaceutical industry SMi’s 2nd annual Wearable Injectors and Connected Devices Conference will explore real world case studies of on-body device design and development for large volume delivery while engaging in the latest digital applications for wearable devices with industry case studies from pharma […]

Returning for its 2nd year as the world’s leading industry forum, Dry-AMD Therapeutic Development establishes meaningful clinical endpoints using the latest diagnostic imaging techniques to prove therapeutic safety and efficacy in specific patient populations. In the context of unprecedented Phase III progress, and as new investigational pharmacological agents enter the clinic, Dry-AMD Therapeutic Development will deliver […]

Exploring therapeutic applications of connected on-body devices The global wearable biosensors market is a rapidly expanding industry with increasingly growing potential for applications in healthcare and technological advances. With potential in remote patient monitoring, diagnosis and detection of disease, biosensors and wearable devices are gaining substantial interest due to their opportunities to offer continuous and […]

As the most comprehensive, industry-focused and ‘must-attend’ event in the field, the 4th Targeted Protein Degradation Summit returns to once again explore the latest approaches, perspectives, and data-drive case studies that will continue to advance PROTACs, molecular glues, and other degrader modalities towards clinical success. With 70+ world-class speakers and over 500 senior attendees from […]

Discover the Intricacies of Complement Pathways to Accelerate Clinical Validation & Maximize Complement-Targeting in the Pan-Disease Setting Built with Alexion, Apellis and Annexon, the 5th Complement-based Drug Development Summit returns for its fifth year as the definitive industry dedicated forum to maximize complement-targeting in the pan-disease setting. With pivotal clinical readouts poised to be released […]

Your Comprehensive End-to-End Guide to Transforming the Clinical Development of Cell & Vaccine Based Neoantigen Therapies The growth and comeback of the neoantigen space has resulted in an abundance of new data, innovative insights and valuable lessons learned on how to drive meaningful clinical responses, all of which will be shared at the 6th Neoantigen […]

At the virtual 2nd Supply Chain and Logistics for Cell Therapies Summit, your community will gather to network, share exclusive insights in case-study led sessions, and propose best practice for seamless vein-to-vein delivery at the clinical and commercial scale. Implement robust, patient-centric supply chains for clinical to commercial readiness: Build your supply strategyand manage risk and forecasting at scale by designing for […]

Real-world evidence is at the root of an ongoing and critical transformation in medical care. By incorporating data from the real world into their development programs, drug developers can now improve their clinical trial success by identifying and retaining suitable patients through increased patient stratification. These are exciting times to reunite at the 9th Advanced Real-World […]

The series brings together a global audience and global lineup of biocatalyst and protein modifications specialists to share how to implement the new technologies. With the applications growing across pharmaceutical, flavour & fragrance, consumer goods, food & beverage and agrochemical sectors, we have created a protein and enzyme engineering platform that will allow the community […]

The 5th Antifibrotic Drug Development Summit will provide a unique opportunity to gain cross-discipline actionable insights into how the latest scientific research is being applied to fibrosis pipeline progress. Network with industry pioneers in hot areas of drug development, specifically IPF, NASH, scleroderma, IBD, ILD, CKD, and more to apply disease-specific lessons agnostically, and understand […]

The Gastrointestinal Cancer Drug Development Summit is the only biopharma-led conference dedicated to identifying and progressing therapeutic opportunities in targeted and immunotherapies, ADCs, and precision oncology to address the large unmet clinical need in GI cancers. **This meeting is free-to-attend for drug developers, research institutions, and not-for-profit organizations**. Register free to attend here: https://ter.li/t83wdr    This industry-dedicated […]

Understanding the most recent developments in enzyme-catalyzed processes, computational technologies, and cutting-edge methodologies in biocatalytic cascade reactions is key to help the API and chemical industries apply biocatalysis more effectively. Specifically designed alongside experts in the field, this conference will delve into the key technology, enzyme design, manufacturing, and scale-up challenges that must be overcome […]

LEAP TA: Life Sciences is a unique open platform for the boldest talent leaders in the industry to engage in genuinely disruptive dialogues. Meet 80+ of your peers to rethink your recruitment approach, allowing you to find better people faster in an increasingly competitive talent market. Taking part in this live online event will help you […]

As reports predict the global biomarker test market will exceed $16bn in coming years, the ability to identify and utilize predictive, diagnostic and prognostic biomarkers is a priority for drug developers. In rare disease, affecting over 400 million worldwide and where clinical insights exist for only around 400 of the 7000+ disease identified, biomarkers are […]

Navigating new legislations and strategies to comply with regulatory requirements SMi is proud to announce the launch of their Medical Devices and IVD conference to be held in London in November 2021. The MDR and IVDR updates will have a profound impact on the medical device industry, bringing certain products into regulatory scope that were […]

In the unprecedented array, and steady stream of novel, topical, and systemic agents entering various phases of drug development, for critical inflammatory and autoimmune dermatological conditions this year, the 5th Annual Dermatology Drug Development Summit for Inflammatory Skin Diseases, returns to Boston for 2021. As the world’s leading, and only forum committed to overcoming significant R&D hurdles, and sharing […]

Discover the Intricacies of Inflammasome Regulation, Leverage Inflammasome Proteins as Biomarkers & Accelerate Novel Inflammasome Therapeutics into Proof-Of-Concept Clinical Trials & Beyond Built with Ventus Therapeutics, Inflammasome Therapeutics, Merck & more, the Inflammasome Therapeutics Summit returns for its third year as the only industry-dedicated forum to discover the intricacies of inflammasome regulation and accelerate novel […]